Recent Press Releases

ICON Reports Second Quarter 2014 and Increases Earnings Guidance

Quarter 2 net revenue increased 12.5% year on year to $376 million. Income from operations was $48.3 million or 12.8% of revenue. Earnings per share were 64 cents. Gross business wins were...

Charles River Laboratories Announces Second-Quarter 2014 Results from Continuing Operations

– Second-Quarter Revenue of $341.2 Million – – Second-Quarter GAAP Earnings per Share of $0.75 and Non-GAAP Earnings per Share of $0.97 – – Updates EPS Guidance for 2014...

Ventana paves the way for companion diagnostic early phase clinical trials in China to advance patient care

Tucson, Ariz., August 5, 2014 - Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group,today announces a new agreement with Quintiles, Inc. to offer College of American Pathology...

PAREXEL International Reports Fourth Quarter And Fiscal Year 2014 Results

BOSTON, Aug. 6, 2014 -- Fourth Quarter Fiscal Year 2014 Results (compared to Fourth Quarter Fiscal Year 2013) 10.2% growth in consolidated service revenue to $510.6 million GAAP...

Tigermed and Frontage Laboratories Complete Strategic Investment Agreement

EXTON, Pa.--Hangzhou Tigermed Consulting Co., Ltd. and Frontage Laboratories, Inc. today announced completion of the previously announced investment agreement, following approval by the China...

Accovion Announces New International Structure for Clinical Operations

FRANKFURT & ESCHBORN, Germany--Accovion announced today a new international structure for its clinical operations designed to facilitate the company's strategic plans for growth throughout...

genae Opens Offices in London

ANTWERP, Belgium and LONDON -- genae, a global Contract Research Organization (CRO) and services provider for the medical industries, announced today the incorporation of genae UK in London. The...

Pfizer and Roche Join ADDPLAN DF Consortium

New members join Novartis, Janssen, and Eli Lilly to develop adaptive design and execution methodologies for improved decision-making in exploratory studies Dublin, Ireland – ICON plc...

Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis

BOSTON and NOTTINGHAM, England, July 31, 2014 -- Columbia Laboratories, Inc. (NASDAQ: CBRX) today announced that its subsidiary, Molecular Profiles Ltd., and XenoGesis Ltd., have announced a...

Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million

PRINCETON, N.J., July 29, 2014 -- Covance Inc. (NYSE: CVD) today reported results for its second quarter ended June 30, 2014. Net revenue was $639 million, representing 8.0% growth from the second...

Catalent, Inc. Announces Pricing Of Its Initial Public Offering

Somerset, N.J. – July 31, 2014 — Catalent, Inc. ("Catalent"), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and...

TFS, Top Sweden-Based Contract Research Organization, Selects OmniComm(R) TrialMaster(R) for Global Clinical Trial Research

TrialMaster Selected to Support Global Trial Expansion FORT LAUDERDALE, FL--OmniComm Systems, Inc. (OTCQB: OMCM), a global leading provider of clinical data management technology, is pleased to...

AIBioTech Settles Government Complaint

RICHMOND, Va.--American International Biotechnology, LLC ("AIBioTech") recently reached a settlement with the U.S. Department of Justice to fully resolve allegations about a contract sales...

Rich Pharmaceuticals Hires Contract Research Organization to File NDA and Identify Clinical Trial Site(s) for Lead Compound

BEVERLY HILLS, Calif. -- Rich Pharmaceuticals, Inc. (OTCQB:RCHA) ("Rich" or the "Company") announced the company has hired San Diego, CA based contract research organization (CRO)...

Horizon Discovery and Otsuka Pharmaceutical Development and Commercialization Sign Collaboration Agreement

Horizon CombinatoRx to perform in-vitro cell line screening of OPDC clinical stage development candidates Cambridge, UK: Horizon Discovery Group plc (LSE:HZD) (Horizon), a leading provider of...

ABL, Inc. Acquires Majority Interest in Platine Pharma Services

ROCKVILLE, Md.--ABL, Inc. (ABL), a biomedical contract research and manufacturing organization to the biopharmaceutical industry, is pleased to announce the acquisition of a majority interest in...

ICON and the University of Cambridge Collaborate to Deliver Educational Programme on Pricing & Market Access Strategy

Dublin, Ireland – ICON plc, (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that its...

TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform

TEANECK, N.J. -- Cognizant (NASDAQ: CTSH) today announced that it has been selected byTransCelerate BioPharma Inc., a non-profit organization with membership representation from 19 major...

National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS

MENLO PARK, Calif. -- SRI International has been awarded a new $49 million, seven-year contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes...

Basilea to launch Zevtera(R)/Mabelio(R) (ceftobiprole medocaril) in Europe through a commercial services provider

Basel, Switzerland, July 21, 2014 - Basilea Pharmaceutica Ltd. (six:BSLN) reports that it has entered into an agreement with Quintiles for the commercialization of Zevtera(R)/Mabelio(R)...